Journal
NUCLEIC ACIDS RESEARCH
Volume 39, Issue 10, Pages 4284-4299Publisher
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkq1224
Keywords
-
Categories
Funding
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- Federation of the Societies of Biochemistry and Molecular Biology
- Netherlands Genomics Initiative [050-71-555]
- BBSRC [BB/F012802/1] Funding Source: UKRI
- MRC [MC_U105663140, MC_U105697135] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/F012802/1] Funding Source: researchfish
- Medical Research Council [MC_U105697135, MC_U105663140] Funding Source: researchfish
Ask authors/readers for more resources
Here we show that c17orf42, hereafter TEFM (transcription elongation factor of mitochondria), makes a critical contribution to mitochondrial transcription. Inactivation of TEFM in cells by RNA interference results in respiratory incompetence owing to decreased levels of H- and L-strand promoter-distal mitochondrial transcripts. Affinity purification of TEFM from human mitochondria yielded a complex comprising mitochondrial transcripts, mitochondrial RNA polymerase (POLRMT), pentatricopeptide repeat domain 3 protein (PTCD3), and a putative DEAD-box RNA helicase, DHX30. After RNase treatment only POLRMT remained associated with TEFM, and in human cultured cells TEFM formed foci coincident with newly synthesized mitochondrial RNA. Based on deletion mutants, TEFM interacts with the catalytic region of POLRMT, and in vitro TEFM enhanced POLRMT processivity on ss- and dsDNA templates. TEFM contains two HhH motifs and a Ribonuclease H fold, similar to the nuclear transcription elongation regulator Spt6. These findings lead us to propose that TEFM is a mitochondrial transcription elongation factor.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available